Dr. Reddy's Laboratories — Fact Sheet (August 2011)

2 slides from Dr. Reddy's Laboratories's fact sheet, August 2011

Slide 1: Key Company updates
Key Company updates: Launched darbepoetin alfa in India under the brand name "Cresp@” +» Launched limited/ no competition products - tacrolimus, lansoprazole, fexo-pseudo 24 hrs in the US ‘+ Acquires GSK's US Penicillin facility and products «Expanded portfolio in Russia & CIS through in-licensing d
Slide 2: Financial Results: FY11
Financial Results: FY11 + Revenue: 27,469 crs + Adjusted EBIDTA: 71,642 crs. + Adjusted PAT: €1,076 crs + Globally 135 new product launches & 163 product filings Note: Adjustments include non-cash impairment of Rs. 860 ers and one time betapharm restructuring costs of Rs. 91 crs in FY10 and profit f